Table of Contents
Cover image

Clinical benefit and graft viability have been found to be sustained for up to 4 y after transplantation of human embryonic dopaminergic tissue for advanced Parkinson disease. Changes in imaging measures, as shown by these maps of mean striatal 18F-FDOPA uptake in transplant recipients, were associated with clinical outcome over the entire posttransplantation time course.
See page 7.